| pubmed-article:12845415 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12845415 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:12845415 | lifeskim:mentions | umls-concept:C0009079 | lld:lifeskim |
| pubmed-article:12845415 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:12845415 | lifeskim:mentions | umls-concept:C0171023 | lld:lifeskim |
| pubmed-article:12845415 | lifeskim:mentions | umls-concept:C0221765 | lld:lifeskim |
| pubmed-article:12845415 | lifeskim:mentions | umls-concept:C1516691 | lld:lifeskim |
| pubmed-article:12845415 | pubmed:issue | 3-4 | lld:pubmed |
| pubmed-article:12845415 | pubmed:dateCreated | 2003-10-7 | lld:pubmed |
| pubmed-article:12845415 | pubmed:abstractText | Schizophrenia patients are known to manifest widespread, multifaceted cognitive deficits. There is now an increasing emphasis on the critical importance of cognitive deficits for the functional outcome in schizophrenia. Typical antipsychotics, although effective in reducing positive symptoms of the illness, have not shown much effect on cognitive functions. Atypical antipsychotics have shown promise of improving some cognitive functions. | lld:pubmed |
| pubmed-article:12845415 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12845415 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12845415 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12845415 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12845415 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12845415 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12845415 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12845415 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12845415 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12845415 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:12845415 | pubmed:issn | 0033-3158 | lld:pubmed |
| pubmed-article:12845415 | pubmed:author | pubmed-author:SharmaTonmoyT | lld:pubmed |
| pubmed-article:12845415 | pubmed:author | pubmed-author:KumariVeenaV | lld:pubmed |
| pubmed-article:12845415 | pubmed:author | pubmed-author:SoniWilliamW | lld:pubmed |
| pubmed-article:12845415 | pubmed:author | pubmed-author:HughesCatheri... | lld:pubmed |
| pubmed-article:12845415 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12845415 | pubmed:volume | 169 | lld:pubmed |
| pubmed-article:12845415 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12845415 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12845415 | pubmed:pagination | 398-403 | lld:pubmed |
| pubmed-article:12845415 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
| pubmed-article:12845415 | pubmed:meshHeading | pubmed-meshheading:12845415... | lld:pubmed |
| pubmed-article:12845415 | pubmed:meshHeading | pubmed-meshheading:12845415... | lld:pubmed |
| pubmed-article:12845415 | pubmed:meshHeading | pubmed-meshheading:12845415... | lld:pubmed |
| pubmed-article:12845415 | pubmed:meshHeading | pubmed-meshheading:12845415... | lld:pubmed |
| pubmed-article:12845415 | pubmed:meshHeading | pubmed-meshheading:12845415... | lld:pubmed |
| pubmed-article:12845415 | pubmed:meshHeading | pubmed-meshheading:12845415... | lld:pubmed |
| pubmed-article:12845415 | pubmed:meshHeading | pubmed-meshheading:12845415... | lld:pubmed |
| pubmed-article:12845415 | pubmed:meshHeading | pubmed-meshheading:12845415... | lld:pubmed |
| pubmed-article:12845415 | pubmed:meshHeading | pubmed-meshheading:12845415... | lld:pubmed |
| pubmed-article:12845415 | pubmed:meshHeading | pubmed-meshheading:12845415... | lld:pubmed |
| pubmed-article:12845415 | pubmed:meshHeading | pubmed-meshheading:12845415... | lld:pubmed |
| pubmed-article:12845415 | pubmed:meshHeading | pubmed-meshheading:12845415... | lld:pubmed |
| pubmed-article:12845415 | pubmed:meshHeading | pubmed-meshheading:12845415... | lld:pubmed |
| pubmed-article:12845415 | pubmed:meshHeading | pubmed-meshheading:12845415... | lld:pubmed |
| pubmed-article:12845415 | pubmed:meshHeading | pubmed-meshheading:12845415... | lld:pubmed |
| pubmed-article:12845415 | pubmed:meshHeading | pubmed-meshheading:12845415... | lld:pubmed |
| pubmed-article:12845415 | pubmed:meshHeading | pubmed-meshheading:12845415... | lld:pubmed |
| pubmed-article:12845415 | pubmed:meshHeading | pubmed-meshheading:12845415... | lld:pubmed |
| pubmed-article:12845415 | pubmed:meshHeading | pubmed-meshheading:12845415... | lld:pubmed |
| pubmed-article:12845415 | pubmed:meshHeading | pubmed-meshheading:12845415... | lld:pubmed |
| pubmed-article:12845415 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:12845415 | pubmed:articleTitle | Cognitive effects of olanzapine and clozapine treatment in chronic schizophrenia. | lld:pubmed |
| pubmed-article:12845415 | pubmed:affiliation | Clinical Neuroscience Research Centre, 7 Twisleton Court, Priory Hill, Dartford, DA1 2EN, Kent, UK. t.sharma@psychmed.org.uk | lld:pubmed |
| pubmed-article:12845415 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12845415 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:12845415 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:12845415 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12845415 | lld:pubmed |
